• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Association between lipid profile and clinical outcomes in COVID-19 patients

tetano

Editor, Senior Moderator
Sci Rep


. 2024 May 27;14(1):12139.
doi: 10.1038/s41598-024-62899-y. Association between lipid profile and clinical outcomes in COVID-19 patients

Luis Antonio Ochoa-Ramírez[SUP] 1 [/SUP], Alberto Kousuke De la Herrán Arita[SUP] 2 [/SUP], Jorge Guillermo Sanchez-Zazueta[SUP] 3 [/SUP], Efrén Ríos-Burgueño[SUP] 4 [/SUP], Joel Murillo-Llanes[SUP] 5 [/SUP], Luis Adrián De Jesús-González[SUP] 6 [/SUP], Carlos Noe Farfan-Morales[SUP] 7 [/SUP], Carlos Daniel Cordero-Rivera[SUP] 8 [/SUP], Rosa María Del Ángel[SUP] 8 [/SUP], Alejandra Romero-Utrilla[SUP] 9 [/SUP], Josué Camberos-Barraza[SUP] 2 [/SUP], Marco Antonio Valdez-Flores[SUP] 2 [/SUP], Alejandro Camacho-Zamora[SUP] 2 [/SUP], José Candelario Batiz-Beltrán[SUP] 2 [/SUP], Carla Angulo-Rojo[SUP] 2 [/SUP], Alma Marlene Guadrón-Llanos[SUP] 2 [/SUP], Verónica Judith Picos-Cárdenas[SUP] 2 [/SUP], Claudia Desiree Norzagaray-Valenzuela[SUP] 3 [/SUP], Ángel Radamés Rábago-Monzón[SUP] 2 [/SUP], Jesús Salvador Velarde-Félix[SUP] 1 3 [/SUP], José Manuel Reyes-Ruiz[SUP] 10 11 [/SUP], Juan Fidel Osuna-Ramos[SUP] 12 [/SUP]



Affiliations
Abstract

High-density lipoprotein cholesterol (HDL-c) removes cholesterol, an essential component in lipid rafts, and this cholesterol removal can regulate protein attachment to lipid rafts, modulating their functionality in the immune cell response. Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can alter the lipid profile, there is little information on the role of HDL-c and other lipids in prognostic of the coronavirus disease 2019 (COVID-19) in Mexican population. This study aims to evaluate the predictive value of HDL-c and lipid profile on severity and survival of 102 patients infected with SARS-CoV-2 during the COVID-19 first wave. Our findings, derived from univariate and multivariate Cox proportional hazards regression models, highlighted age and hypertension as significant predictors of survival (HR = 1.04, p = 0.012; HR = 2.78, p = 0.027), while gender, diabetes, and obesity showed no significant impact. Triglycerides and HDL-c levels notably influenced mortality, with elevated triglycerides and lower HDL-c associated with higher mortality risk (p = 0.032). This study underscores the importance of lipid profiles alongside traditional risk factors in assessing COVID-19 risk and outcomes. It contributes to the understanding of COVID-19 patient management and emphasizes the need for further investigation into the role of dyslipidemia in influencing COVID-19 prognosis, potentially aiding in refined risk stratification and therapeutic strategies.

Keywords: Biomarker; COVID-19 severity; HDL cholesterol; SARS-CoV-2.

 
Back
Top Bottom